Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

13.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying institutional gender inequality in contemporary visual art.

Nature communications·2026
Same author

Inferring and evaluating network medicine-based disease modules with nextflow.

Bioinformatics (Oxford, England)·2026
Same author

Network-driven discovery of repurposable drugs targeting hallmarks of aging.

Nature aging·2026
Same author

Cortical development dynamics across autism spectrum disorder mouse models.

Nature·2026
Same author

The aging genome exhibits organized vulnerability to somatic mutations.

bioRxiv : the preprint server for biology·2026
Same author

Hungary's chance to rebuild science.

Science (New York, N.Y.)·2026

Related Experiment Video

Updated: Mar 26, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K

Network-based in silico drug efficacy screening.

Emre Guney1,2, Jörg Menche1,3, Marc Vidal2,4

  • 1Center for Complex Networks Research (CCNR) and Department of Physics, Northeastern University, 177 Huntington Avenue, 11th floor, Boston, Massachusetts 02115, USA.

Nature Communications
|February 3, 2016
PubMed
Summary
This summary is machine-generated.

Innovative network analysis reveals a drug-disease proximity measure to predict drug efficacy and identify new therapeutic uses. This approach helps uncover treatments and improve drug discovery by analyzing disease gene networks.

More Related Videos

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.9K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.7K

Related Experiment Videos

Last Updated: Mar 26, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.9K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.7K

Area of Science:

  • Systems biology
  • Pharmacology
  • Bioinformatics

Background:

  • Rising drug development costs and declining new drug approvals necessitate novel approaches for target identification and efficacy prediction.
  • Understanding disease origins through network biology provides a foundation for new analytical methods.

Purpose of the Study:

  • To introduce a drug-disease proximity measure quantifying the interplay between drug targets and diseases.
  • To correct for known interactome biases and uncover the therapeutic effects of drugs.
  • To distinguish between palliative and effective treatments and predict novel drug-disease associations.

Main Methods:

  • Development and application of a network-based drug-disease proximity measure.
  • Analysis of 238 drugs across 78 diseases, correcting for interactome biases.
  • Utilizing gene network proximity to assess drug efficacy and predict associations.

Main Results:

  • Drug therapeutic effects are localized within a small network neighborhood of disease genes.
  • Identified potential efficacy issues for drugs treating Parkinson's disease and inflammatory disorders.
  • Demonstrated the ability of network-based proximity to predict novel drug-disease links.

Conclusions:

  • Network-based proximity is a valuable tool for target identification and efficacy prediction in drug development.
  • This measure aids in understanding drug mechanisms, identifying treatment limitations, and discovering new therapeutic applications through drug repurposing.
  • The approach offers significant potential for advancing pharmaceutical research and improving patient outcomes.